Literature DB >> 26516446

Genetic characterization of the wboA gene from the predominant biovars of Brucella isolates in Iran.

Afshar Etemady1, Mohsen Mohammdi2, Majid Esmaelizad3, Saeed Alamian1, Fatemeh Vahedi4, Khosro Aghaeipour3, Ali Mohammad Behrozikhah1, Ebrahim Faghihloo5, Davoud Afshar6, Sajad Firuzyar7, Arian Rahimi8.   

Abstract

INTRODUCTION: Brucella spp. are gram-negative, facultative intracellular bacteria pathogens responsible for brucellosis, a zoonotic disease that can cause abortion, fetal death, and genital infections in animals and undulant fever in humans. Lipopolysaccharide (LPS) is known as a major virulence factor of Brucella spp. The wboA gene is capable of encoding a glycosyltransferase that appears to play a major role in LPS biosynthesis. Hence, the characterization of this gene can help in the clarification of the pathogenicity of Brucella spp.
METHODS: This study was carried out at Razi Vaccine and Serum Research Institute in 2011. Briefly, the wboA gene in B. abortus biovar 3 and B. melitensis biovar 1, the predominant biovars in Iran, were amplified by using two pairs of specific primers. Polymerase chain reaction (PCR) products were cloned into a thymine-adenine (TA) cloning vector and transformed into an E. coli DH5α before being sequenced. Multiple alignments of identified sequences were performed, with all wboA sequences deposited in the GenBank sequence database.
RESULTS: This study showed that a mismatch has occurred in B. melitensis biovar 1; this biovar is predominant in Iran. In contrast, the wboA gene from B. abortus biovar 3 was similar to that of other B. abortus variations.
CONCLUSION: The comparison and alignment of the wboA gene of native Brucella strains in Iran to all wboA sequences deposited in GenBank revealed that the wboA gene has changed in the long term; hence, because of its unique nucleotide pattern, the gene can be used for specific diagnosis of B. abortus and B. canis.

Entities:  

Keywords:  B. abortus; Brucella; LPS; wboA gene

Year:  2015        PMID: 26516446      PMCID: PMC4623799          DOI: 10.14661/1381

Source DB:  PubMed          Journal:  Electron Physician        ISSN: 2008-5842


1. Introduction

The Brucella genus consists of facultative intracellular, non-motile, aerobic, gram-negative coccobacilli bacteria that create brucellosis disease, a zoonotic disease that causes abortion, fetal death, and genital infections in animals, and it is one of the most important zoonotic diseases with respect to public health concerns (1). Brucella belongs to class 2 Alphaproteobacteria, order Rhizobiales, family Brucellceae, and genus Brucella (2). The genus according to host specificity and pathogenicity is composed of 10 recognized species, six of which are considered the classic species, Brucella abortus (seven biovars), B. melitensis (three biovars), B. suis (five biovars), B. canis, B. ovis, and B. neotomae. The four species newly isolated from sea mammals are B. ceti, B. pinnipedialis, B. microti, and B. inopinata (3, 4). B. melitensis, B. suis, B. abortus, and (rarely) B. canis are responsible for human infections, with B. abortus having the widest geographic distribution (4–6). Many countries have taken steps to control disease related to B. abortus, but regions still exist where the infection is present in animals and therefore may be transmitted to humans (7). The major means of B. abortus transmission to humans (i.e., brucellosis) include direct contact with infectious animals’ tissues, inhalation of aerosolized droplets, and consumption of unpasteurized dairy products (8). B. abortus biovar 1 is reported as the most frequent biovar in comparison to other varieties, and it contributes to brucellosis in many countries across the world. In Mediterranean countries, B. melitensis biovar 3 has been identified as the most frequent biovar (9). In Iran, the results of epidemiologic studies have shown that B. abortus biovar 3 and B. melitensis biovar 1 are the dominant biovars (10). Brucella’s outer membrane, as with other gram-negative bacteria, is an asymmetrical lipid bilayer composed of lipopolysaccharide (LPS), proteins, and phospholipids (PLs); LPS and PLs are located in the outer and inner membrane, respectively (11, 12). Depending on its structure, LPS can be smooth (S-LPS) or rough (R-LPS). These two types of LPS have many functions, including substrate transportation and genetic exchanges, and they also are considered to be a determining factor in virulence of the pathogen. Specifically, S-LPS (because of its external position) has an important role in many host–pathogen interactions, and it is the immunodominant antigen of Brucella (13, 14). LPS is composed of two connected portions, i.e., the lipid A-core and the o-polysaccharide. The details of the structures of Brucella vary among the different bacteria. O-polysaccharide (due to compositional subunits) can be either homopolymeric or heteropolymeric (15). Brucella species with a smooth phenotype (B. abortus, B. melitensis, B. suis, B. neotomae) have an O-side chain in their LPS structure, while naturally rough phenotypes (such as B. canis and B. ovis) lack the O-polysaccharide side chain. The genes involved in O-polysaccharide synthesis are located in two genetic regions, wbo and wbk, which have activity in polysaccharide synthesis and translocation, respectively (16). The wboA gene is capable of encoding a glycosyltransferase (wboA-wboB) that is important for O-antigen synthesis of the Brucella (17, 18). Studies have shown that the wboA gene is conserved in B. canis (rough phenotype) as well as in other Brucella species with a smooth phenotype (18, 19). Since LPS is known to be a major virulence factor of Brucella spp, characterization of the gene involved in LPS biosynthesis can help demonstrate the mechanism of the pathogenicity of Brucella as well as demonstrate its level of virulence. Furthermore, this characterization can clarify the relationship between genotype and phenotype and their use in differential diagnosis as well as approaches in the development of novel recombinant vaccine.

2. Material and Methods

2.1. Research design and setting

This research was conducted at Razi Vaccine and Serum Research Institute of Iran in 2011. The bacterial strains used in this study are listed in Table 1. All Brucella strains were grown on Brucella broth and/or agar media at 37 °C for 72 h. The colonies were checked for purity, and the species and biovar were characterized using standard procedures.
Table 1

Brucellal strains used in this study

SpeciesSpecies BiovarsHost or sourceGeographic originStrain or Accession No.
B. abortus3Cow milk and aborted fetusesIsfahan (Iran)HQ845203.1
B. melitensis1Cow milkGolpyegan (Iran)JF261627.1
B. abortus1CattleEnglandReference strain: 544 (= ATCC 23448)
B. melitensis1GoatUSAReference strain: 16M (= ATCC 23456)

2.2. DNA Extraction and PCR

The bacterial suspension was centrifuged at 2500 g for 5 min, and the pellet was resuspended in 200 μl of phosphate buffer solution, and DNA was extracted using a QIAamp DNA Mini Kit (Qiagen) according to the manufacturer’s instructions. The extracted DNA was evaluated by gel electrophoresis using a 1.0% agarose gel (20). The wboA gene was amplified using primers F: 5- GAGTAGACACGGGAAATC-3 and R: 5- GATAAACACGCCGAGCTT-3. The primers were designed using oligo software based on the wboA sequence available in the National Center for Biotechnology Information (NCBI) database. Amplification consisted of an initial denaturation step of 5 min at 94 °C followed by 30 cycles at 94 °C for 30 s, 55 °C for 30 s, 72 °C for 90 s, and with a final extension at 72 °C for 8 min. After confirming the size of the product, the product was purified using PCR product Purification Kit according to the manufacturer’s instructions (Qiagen).

2.3. Cloning and sequencing

PCR products were cloned using an Ins TA clone PCR Cloning Kit (Thermo Scientific) according to the manufacturer’s instructions. The transformation was performed using competent E. coli DH5 α cells. Colony screening was done for ampicillin resistance. The plasmids that contained the wboA gene were extracted using the high purity plasmid isolation kit (Roche) and sequenced.

2.4. Amino acid sequence alignment

The alignment of Iranian native biovars’ sequences with the others Brucella species including B. abortus, B. melitensis, B. suis, B. canis, B. microti, B.pinipeialis, and B.ctei. were performed using MegAlign (DNASTAR, Inc.) software.

3. Results

The nucleotide sequence of wboA gene belonging to B. abortus biovar 3 and B. melitensis biovar 1 (predominant species in Iran) were submitted to GenBank with accession numbers HQ845203.1 and JF261627.1, respectively. Comparative nucleotide and deduced amino acid sequence of the wboA among all Brucella species and predominant biovars in Iran showed that the wboA gene is highly conserved, but with a low number of point mutations. The wboA sequense analysis of B. melitensis biovar 1 in Iran showed a nucleotide substitution in position 335 that was unique in comparison with the other Brucella species. This nucleotide mutation caused an amino acid change as a missense mutation (aspartic acid to glycine) (Figure 1).
Figure 1

(1-A), wboA nucleotic subsituation in Brucella melitensis biovar; (1-B), Variation in glycosyltransferase amino acid sequence in Brucella melitensis biovar 1

The nucleotide sequence of the wboA gene from B. abortus biovar 3 (another predominant biovar) was similar to all B. abortus variants submitted to GenBank. Alignment of the wboA sequences among all Brucella species revealed unique patterns, such as the presence of a single nucleotide polymorphism at position 987, which can be used for specific differentiation of B. abortus from other Brucella species (Figure 2), and two nucleotide substitutions in position 1182 that also caused a missense mutation (tryptophan to tyrosine). This specific substitution pattern is suitable for discriminating B. canis from other Brucella species (Figure 3).
Figure 2

Brucella abortus Specific pattern in the wboA gene

Figure 3

(3-A), Brucella canis Specific pattern in the wboA gene; (3-B), Variation in glycosyltransferase amino acid sequence in Brucella canis

4. Discussion

The wide range of different Brucella species makes Brucella a subtle model for the investigation of pathogenic bacteria. Brucella spp. belong to alpha-2 proteobacteria that have a nucleotide sequence of two circular chromosomes with more than three mega base pairs. Whole-genome comparative analysis showed more than 94% identity at the nucleotide level (6, 10, 21, 22). The O-polysaccharide in LPS structures has polymers of sugar groups; a large family of polymerase enzymes, called glycosyltransferases (GTs), forms glycoside bonds between sugar residues. The presence of these enzymes in a eukaryotic and prokaryotic cell has been established. Based on crystal structure, GTs are divided into two super families, i.e., GTA and GTB. A mutation in genes encodes the O-polysaccharide due to the conversion of the smooth phenotype to the rough phenotype. Previous studies have shown disruption of wboA in Brucella species that have a smooth phenotype, such as B. abortus, B. melitensis, and B. suis, which the can be converted to the rough phenotype. These mutated strains were not able to produce O-polysaccharide in an LPS structure (15–17, 23, 24). The wboA is a suitable candidate for increasing the coverage provided by brucellosis vaccine strains and decreasing the side effects produced by similar antibodies in response to the wild and vaccine strains in test and slaughter programs (18, 19). In Brucella spp., the wboA gene is composed of 1,233 base pairs that encode glycosyltransferase enzyme. This enzyme acts to polymerize O-polysaccharide. In this study, the wboA sequences for the dominant Brucella biovars in Iran (B. abortus biovar 3 and B. melitensis biovar 1) were characterized and aligned with all sequences of the wboA that belonged to Brucella species in a comparative analysis. The results showed a unique nucleotide mutation in B. melitensis biovar 1 that caused an amino acid substitution. This strain originally was isolated from cow’s milk; one interesting point is that penicillin sensitivity was present as a phenotypic feature. This is a novel report of genetic changes in wboA and phenotypic differences based on the wboA sequence. The phylogenetic tree exhibited considerable genetic diversity in B. melitensis biovar 1. Atypical features, such as sensitivity to dye and penicillin in B. melitensis biovar 1, have been reported in previous studies. Variations of bacteria porins (outer membrane proteins in gram-negative bacteria) in the LPS structure have been mentioned as the causative agent of these phenotypic characteristics (25). The nucleotide sequence of the wboA gene in B. abortus biovar 3 was the same as that for all B. abortus wboA sequences deposited in GenBank, confirming the genetic conservation of wboA in B. abortus strains. The novelty of the present study was the presentation of the wboA gene as a genetic element for detection of B. abortus and B. canis. The results revealed that the point mutation of the wboA gene in native B. melitensis is correlated with changes in phenotype features.

5. Conclusions

Unique nucleotide substitution in wboA sequence of B. melitensis bivar 1 resulted in missense mutation. Regarding the function of the wboA gene in O side chain biosynthesis, it may be involved in colony morphology variations.
  23 in total

Review 1.  Brucellosis--new aspects of an old disease.

Authors:  S J Cutler; A M Whatmore; N J Commander
Journal:  J Appl Microbiol       Date:  2005       Impact factor: 3.772

2.  Molecular characterisation of Brucella species.

Authors:  H C Scholz; G Vergnaud
Journal:  Rev Sci Tech       Date:  2013-04       Impact factor: 1.181

3.  An overview of the epidemiology and epizootology of brucellosis in selected countries of Central and Southeast Europe.

Authors:  V Taleski; L Zerva; T Kantardjiev; Z Cvetnic; M Erski-Biljic; B Nikolovski; J Bosnjakovski; V Katalinic-Jankovic; A Panteliadou; S Stojkoski; T Kirandziski
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

Review 4.  Brucellosis vaccines: past, present and future.

Authors:  Gerhardt G Schurig; Nammalwar Sriranganathan; Michael J Corbel
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

5.  Immunochemical characterization of rough Brucella lipopolysaccharides.

Authors:  E Moreno; L M Jones; D T Berman
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

Review 6.  Brucellosis: a re-emerging zoonosis.

Authors:  Mohamed N Seleem; Stephen M Boyle; Nammalwar Sriranganathan
Journal:  Vet Microbiol       Date:  2009-06-21       Impact factor: 3.293

7.  Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages.

Authors:  F Godfroid; B Taminiau; I Danese; P Denoel; A Tibor; V Weynants; A Cloeckaert; J Godfroid; J J Letesson
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides.

Authors:  G Martínez de Tejada; J Pizarro-Cerdá; E Moreno; I Moriyón
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

9.  Changes of predominant species/biovars and sequence types of Brucella isolates, Inner Mongolia, China.

Authors:  Yanfen Chen; Yuehua Ke; Yufei Wang; Xitong Yuan; Xiaoyan Zhou; Hai Jiang; Zhoujia Wang; Qing Zhen; Yaqin Yu; Liuyu Huang; Buyun Cui; Zeliang Chen
Journal:  BMC Infect Dis       Date:  2013-11-01       Impact factor: 3.090

10.  DNA polymorphism analysis of Brucella lipopolysaccharide genes reveals marked differences in O-polysaccharide biosynthetic genes between smooth and rough Brucella species and novel species-specific markers.

Authors:  Michel S Zygmunt; José M Blasco; Jean-Jacques Letesson; Axel Cloeckaert; Ignacio Moriyón
Journal:  BMC Microbiol       Date:  2009-05-13       Impact factor: 3.605

View more
  1 in total

1.  A Novel PCR Assay for Detecting Brucella abortus and Brucella melitensis.

Authors:  Saeed Alamian; Majid Esmaelizad; Taghi Zahraei; Afshar Etemadi; Mohsen Mohammadi; Davoud Afshar; Soheila Ghaderi
Journal:  Osong Public Health Res Perspect       Date:  2017-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.